Patidar Build is not listed on NSE
52 Week HighPatidar Build has hit a 52wk high of Rs 99.60 on BSE
52 Week HighPatidar Build has hit a 52wk high of Rs 94.90 on BSE
52 Week HighPatidar Build has hit a 52wk high of Rs 90.40 on BSE
52 Week HighPatidar Build has hit a 52wk high of Rs 86.10 on BSE
AnnouncementsPatidar Buildcon appoints independent director
|Company Name||Last Price||%
|Dr Reddys Labs||2431.10||-0.80||2545.00||1764.00||41,352.95|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Patidar Build is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 67.00 crore.The company has reported a standalone sales of Rs 0.58 crore and a Net Profit of Rs 0.05 crore for the quarter ended Sep 2013.
The company management includes Rajnikant Patel - Whole Time Director, Dhirajlal Patel - Director, Ekta Maheshwari - Director, Ishvarbhai Patel - Director, Kirit Kumar Khetani - Independent Director, Navinchandra Parmar - Independent Director.
It is listed on the BSE with a BSE Code of 524031.
Its Registered office is at Lati Bazar, Joravar Nagar , Surendra Nagar Dist,Gujarat - 363020.
Their Registrars are Adroit Corporate Service (P) Ltd.